SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CEPH

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: KurtVedder who wrote (359)5/20/1997 7:21:00 PM
From: WeirdPro Randy   of 998
 
I may be very bullish on CEPH, but it is the street or the market makers who are the most bullish.

Almost 2 weeks following the advisory comittee, we find CEPH at 13....and has not really budged, seeming to be maintaining a resistance at 12 3/8-12 1/2.

Don't think anyone knows the short term prospects regarding the FDA and myotrophin, but it seems the long at this point remain long and the bargain seekers are not going to see < 12 very easily.

More importantly, the FDA is just one of three possibilities to create an exciting jump in CEPH.....the other two being European approval and modafinil. Ceph is going up soon, how soon is my only unknown.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext